Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2011 - 2026)

Rigel Pharmaceuticals' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.59 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 50.72% year-over-year to 0.59 in Q1 2026; TTM through Mar 2026 was 0.59, a 50.72% decrease from a year earlier, with the FY2025 full-year figure at 0.87, down 31.88% from the prior year.
• Asset Utilization Ratio eased to 0.59 in Q1 2026 per RIGL's latest filing, from 0.78 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.4 in Q2 2025 and bottomed at 0.54 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 1.01 (2023), against an average of 0.98.
• Across the five-year window, Asset Utilization Ratio soared 87.13% in 2023 and plunged 50.72% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.96 in 2022, then advanced by 4.45% to 1.01 in 2023, then increased by 17.57% to 1.18 in 2024, then plunged by 34.14% to 0.78 in 2025, then slipped by 24.35% to 0.59 in 2026.
• Per Business Quant, the three latest RIGL Asset Utilization Ratio figures stand at 0.59 (Q1 2026), 0.78 (Q4 2025), and 1.26 (Q3 2025).